65 related articles for article (PubMed ID: 23397419)
21. Phase separation is induced by phenothiazine derivatives in phospholipid/sphingomyelin/cholesterol mixtures containing low levels of cholesterol and sphingomyelin.
Hendrich AB; Michalak K; Wesołowska O
Biophys Chem; 2007 Oct; 130(1-2):32-40. PubMed ID: 17662517
[TBL] [Abstract][Full Text] [Related]
22. Glycosidated phospholipids - a promising group of anti-tumour lipids.
Semini G; Hildmann A; von Haefen C; Danker K
Anticancer Agents Med Chem; 2014 May; 14(4):607-17. PubMed ID: 24628240
[TBL] [Abstract][Full Text] [Related]
23. Ethanol Induces Extracellular Vesicle Secretion by Altering Lipid Metabolism through the Mitochondria-Associated ER Membranes and Sphingomyelinases.
Ibáñez F; Montesinos J; Area-Gomez E; Guerri C; Pascual M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445139
[TBL] [Abstract][Full Text] [Related]
24. Movement of accessible plasma membrane cholesterol by the GRAMD1 lipid transfer protein complex.
Naito T; Ercan B; Krshnan L; Triebl A; Koh DHZ; Wei FY; Tomizawa K; Torta FT; Wenk MR; Saheki Y
Elife; 2019 Nov; 8():. PubMed ID: 31724953
[TBL] [Abstract][Full Text] [Related]
25. Cholesterol interactions with phospholipids in membranes.
Ohvo-Rekilä H; Ramstedt B; Leppimäki P; Slotte JP
Prog Lipid Res; 2002 Jan; 41(1):66-97. PubMed ID: 11694269
[TBL] [Abstract][Full Text] [Related]
26. Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects.
van Blitterswijk WJ; Verheij M
Curr Pharm Des; 2008; 14(21):2061-74. PubMed ID: 18691116
[TBL] [Abstract][Full Text] [Related]
27. Active membrane cholesterol as a physiological effector.
Lange Y; Steck TL
Chem Phys Lipids; 2016 Sep; 199():74-93. PubMed ID: 26874289
[TBL] [Abstract][Full Text] [Related]
28. Affinity of alkylphosphocholines to biological membrane of prostate cancer: studies in natural and model systems.
Wnętrzak A; Lipiec E; Łątka K; Kwiatek W; Dynarowicz-Łątka P
J Membr Biol; 2014 Jul; 247(7):581-9. PubMed ID: 24848301
[TBL] [Abstract][Full Text] [Related]
29. Unnatural Peptide Assemblies Rapidly Deplete Cholesterol and Potently Inhibit Cancer Cells.
Zhang Q; Tan W; Liu Z; Zhang Y; Wei WS; Fraden S; Xu B
J Am Chem Soc; 2024 May; 146(19):12901-12906. PubMed ID: 38701349
[TBL] [Abstract][Full Text] [Related]
30. Phospholipid translocation in the endoplasmic reticulum.
Devaux PF
Subcell Biochem; 1993; 21():273-85. PubMed ID: 8256270
[No Abstract] [Full Text] [Related]
31. Mass transport in tumors: characterization and applications to chemotherapy.
Jain RK; Weissbrod JM; Wei J
Adv Cancer Res; 1980; 33():251-310. PubMed ID: 7006335
[No Abstract] [Full Text] [Related]
32. Mechanisms of action of phospholipid analogs as anticancer compounds.
Wieder T; Reutter W; Orfanos CE; Geilen CC
Prog Lipid Res; 1999 May; 38(3):249-59. PubMed ID: 10664795
[No Abstract] [Full Text] [Related]
33. Heterocyclic alkylphospholipids with an improved therapeutic range.
Hilgard P; Stekar J; Klenner T; Nössner B; Kutscher B; Engel J
Adv Exp Med Biol; 1996; 416():157-64. PubMed ID: 9131142
[No Abstract] [Full Text] [Related]
34. Dual Gene Delivery Reagents From Antiproliferative Alkylphospholipids for Combined Antitumor Therapy.
Gaillard B; Remy JS; Pons F; Lebeau L
Front Chem; 2020; 8():581260. PubMed ID: 33134279
[TBL] [Abstract][Full Text] [Related]
35. Membranes and cancer chemotherapy.
Burns CP
Cancer Invest; 1988; 6(4):439-51. PubMed ID: 3052704
[No Abstract] [Full Text] [Related]
36. Cell surface sphingomyelin: key role in cancer initiation, progression, and immune evasion.
Tallima H; Azzazy HME; El Ridi R
Lipids Health Dis; 2021 Oct; 20(1):150. PubMed ID: 34717628
[TBL] [Abstract][Full Text] [Related]
37. Lipid efflux mediated by alkylphospholipids in HepG2 cells.
Ríos-Marco P; Segovia JL; Jiménez-López JM; Marco C; Carrasco MP
Cell Biochem Biophys; 2013 Jul; 66(3):737-46. PubMed ID: 23397419
[TBL] [Abstract][Full Text] [Related]
38. Antitumoral alkylphospholipids induce cholesterol efflux from the plasma membrane in HepG2 cells.
Ríos-Marco P; Jiménez-López JM; Marco C; Segovia JL; Carrasco MP
J Pharmacol Exp Ther; 2011 Mar; 336(3):866-73. PubMed ID: 21148684
[TBL] [Abstract][Full Text] [Related]
39. Antitumoral alkylphospholipids alter cell lipid metabolism.
Marco C; Ríos-Marco P; Jiménez-López JM; Segovia JL; Carrasco MP
Anticancer Agents Med Chem; 2014 May; 14(4):545-58. PubMed ID: 24628237
[TBL] [Abstract][Full Text] [Related]
40. Hexadecylphosphocholine alters nonvesicular cholesterol traffic from the plasma membrane to the endoplasmic reticulum and inhibits the synthesis of sphingomyelin in HepG2 cells.
Marco C; Jiménez-López JM; Ríos-Marco P; Segovia JL; Carrasco MP
Int J Biochem Cell Biol; 2009 Jun; 41(6):1296-303. PubMed ID: 19084611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
